title: [Effect of Kuijieling decoction on proteins expression of IKK-alpha in colonic mucosa of ulcerative colitis model rats].
abstract: OBJECTIVE
  To explore the changes of protein expression of IKK-alpha as well as the effects of Kuijieling Decoction (KD) on colonic mucosa of ulcerative colitis (UC) model rats.
  
  
  METHODS
  UC model rats were induced by TNBS. The rats were randomly divided into six groups: normal control (NC) group, model control (MC) group, Kuijieling low dose (KLD), middle dose (KMD) group, high dose (KHD) group and SASP group. After 10-days' treatment the rats were killed to get their colonic tissues. The positive rate of IKK-alpha expression was detected by immunohistochemical (IHC).
  
  
  RESULTS
  The positive rate of IKK-alpha in MC group was significantly higher than that in NC group (P < 0.01). The positive rate of IKK-alpha in KMD group was significantly lower than that in MC group (P < 0.05). The positive rate of IKK-alpha in KHD and SASP group were significantly lower than that in MC group (P < 0.01).
  
  
  CONCLUSIONS
  IKK-alpha may be involved in the pathogenesis of UC, and KD can inhibit positive rate of IKK-alpha in colonic mucosa of UC model rats induced by TNBS. The inhibitory effects of KD on UC may be associated with this.
authors.affiliation: Pi-wei institute, Guangzhou University of TCM, Guangzhou 510405, China.
authors.forename: Qun
authors.initials: Q
authors.lastname: Du
authors.forename: Hong
authors.initials: H
authors.lastname: Li
authors.forename: Ru-Jun
authors.initials: RJ
authors.lastname: Wang
authors.forename: Yan-Wu
authors.initials: YW
authors.lastname: Li
authors.forename: Yan-Li
authors.initials: YL
authors.lastname: Wu
authors.forename: Jian-Hua
authors.initials: JH
authors.lastname: Wang
mesh_terms: D000818:Animals; D003093:Colitis, Ulcerative / Q000139:chemically induced / Q000378:metabolism* / Q000473:pathology; D004195:Disease Models, Animal; D004338:Drug Combinations; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage / Q000494:pharmacology*; D051550:I-kappa B Kinase / Q000378:metabolism*; D007150:Immunohistochemistry; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D010946:Plants, Medicinal / Q000737:chemistry*; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D014302:Trinitrobenzenesulfonic Acid
chemical_list: D004338:Drug Combinations; D004365:Drugs, Chinese Herbal; D014302:Trinitrobenzenesulfonic Acid; D051550:I-kappa B Kinase